Biopharmaceuticals

Contributing Editorial Column By Kenneth E. Thorpe Less than a year after the pandemic began, Americans had access to three highly effective vaccines that are paving the way forward and away from Covid-19, and that number could soon rise, as the FDA considers promising candidates from AstraZeneca and Novavax. The groundbreaking pace of Covid-19 vaccine…